Modified retroperitoneal lymph node dissection for post‐chemotherapy residual tumour: a long‐term update

Abstract

In appropriately selected patients with low-volume disease before and after chemotherapy, a modified template has durable long-term efficacy without risk of in-field recurrences at a median follow-up of 125 months.